Jane Street Group, LLC Infinity Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.46 - $1.21 $67,873 - $178,535	147,550 New	147,550 $82,000
Q4 2021 Feb 15, 2022	SELL	$1.86 - $3.36 $406,400 - $734,143	-218,495 Reduced 87.26%	31,902 $71,000
Q3 2021 Nov 16, 2021	BUY	$1.52 - $3.82 $273,209 - $686,618	179,743 Added 254.4%	250,397 $857,000
Q2 2021 Aug 16, 2021	BUY	$2.66 - $3.47 $86,332 - $112,622	32,456 Added 84.97%	70,654 $212,000
Q1 2021 May 18, 2021	BUY	$1.98 - $5.36 $75,632 - $204,741	38,198 New	38,198 $123,000
Q1 2019 May 16, 2019	SELL	$1.18 - $1.91 $21,460 - $34,737	-18,187 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$1.01 - $2.78 $18,368 - $50,559	18,187 New	18,187 $21,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.